A detailed history of Dagco, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Dagco, Inc. holds 6,468 shares of JNJ stock, worth $934,431. This represents 0.43% of its overall portfolio holdings.

Number of Shares
6,468
Previous 6,719 3.74%
Holding current value
$934,431
Previous $982,000 6.72%
% of portfolio
0.43%
Previous 0.44%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $36,515 - $42,012
-251 Reduced 3.74%
6,468 $1.05 Million
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $29,309 - $32,029
-203 Reduced 2.93%
6,719 $982,000
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $908,502 - $952,517
5,853 Added 547.52%
6,922 $1.09 Million
Q4 2023

Feb 15, 2024

SELL
$145.6 - $158.88 $791,481 - $863,671
-5,436 Reduced 83.57%
1,069 $167,000
Q3 2023

Dec 07, 2023

SELL
$155.75 - $174.48 $430,493 - $482,262
-2,764 Reduced 29.82%
6,505 $1.01 Million
Q2 2023

Jul 31, 2023

SELL
$154.35 - $166.11 $263,784 - $283,881
-1,709 Reduced 15.57%
9,269 $1.53 Million
Q1 2023

May 05, 2023

SELL
$151.05 - $180.26 $207,542 - $247,677
-1,374 Reduced 11.12%
10,978 $1.7 Million
Q4 2022

Feb 09, 2023

SELL
$160.2 - $179.79 $53,186 - $59,690
-332 Reduced 2.62%
12,352 $2.18 Million
Q3 2022

Nov 01, 2022

SELL
$161.33 - $179.52 $9,034 - $10,053
-56 Reduced 0.44%
12,684 $2.01 Million
Q2 2022

Jul 28, 2022

SELL
$168.19 - $186.01 $63,912 - $70,683
-380 Reduced 2.9%
12,740 $2.2 Million
Q1 2022

Apr 21, 2022

SELL
$158.14 - $179.59 $119,870 - $136,129
-758 Reduced 5.46%
13,120 $2.33 Million
Q4 2021

Jan 24, 2022

SELL
$155.93 - $173.01 $150,784 - $167,300
-967 Reduced 6.51%
13,878 $2.37 Million
Q3 2021

Nov 01, 2021

SELL
$161.5 - $179.47 $13,404 - $14,896
-83 Reduced 0.56%
14,845 $2.4 Million
Q2 2021

Jul 12, 2021

SELL
$159.48 - $171.07 $2,711 - $2,908
-17 Reduced 0.11%
14,928 $2.46 Million
Q1 2021

Apr 28, 2021

BUY
$153.07 - $170.48 $71,177 - $79,273
465 Added 3.21%
14,945 $2.46 Million
Q4 2020

Jan 28, 2021

BUY
$137.11 - $157.38 $50,867 - $58,387
371 Added 2.63%
14,480 $2.28 Million
Q3 2020

Oct 19, 2020

SELL
$140.38 - $153.83 $31,164 - $34,150
-222 Reduced 1.55%
14,109 $2.1 Million
Q2 2020

Jul 27, 2020

SELL
$128.81 - $155.51 $30,012 - $36,233
-233 Reduced 1.6%
14,331 $2.02 Million
Q1 2020

Apr 30, 2020

SELL
$111.14 - $153.99 $52,458 - $72,683
-472 Reduced 3.14%
14,564 $1.91 Million
Q4 2019

Feb 06, 2020

BUY
$127.5 - $146.44 $44,880 - $51,546
352 Added 2.4%
15,036 $2.19 Million
Q3 2019

Oct 28, 2019

SELL
$126.95 - $142.14 $12,314 - $13,787
-97 Reduced 0.66%
14,684 $1.9 Million
Q2 2019

Aug 08, 2019

SELL
$131.15 - $144.24 $6,164 - $6,779
-47 Reduced 0.32%
14,781 $2.06 Million
Q1 2019

May 13, 2019

BUY
$125.72 - $139.79 $251 - $279
2 Added 0.01%
14,828 $2.07 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $1.82 Million - $2.19 Million
14,826 New
14,826 $1.91 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Dagco, Inc. Portfolio

Follow Dagco, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dagco, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dagco, Inc. with notifications on news.